Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in multimodal therapy for resectable breast cancer

G Bonadonna

    Israel Journal of Medical Sciences
    |September 1, 1981
    PubMed
    Summary

    Adjuvant chemotherapy using cyclophosphamide, methotrexate, and fluorouracil (CMF) significantly improves survival rates for operable breast cancer patients with positive lymph nodes. Treatment benefits were observed regardless of menopausal or estrogen receptor status.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response of diademed sifaka (<i>Propithecus diadema</i>) to fosa (<i>Cryptoprocta ferox</i>) predation in the Betampona Strict Nature Reserve, Madagascar.

    Ecology and evolution·2024
    Same author

    Degenerative and inflammatory musculoskeletal disorders: updates and hot topics in diagnostic and interventional imaging.

    European review for medical and pharmacological sciences·2022
    Same author

    Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2006
    Same author

    Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005
    Same author

    Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.

    Breast cancer research and treatment·2002

    Area of Science:

    • Oncology
    • Clinical Medicine
    • Cancer Research

    Background:

    • Multimodal therapy is a standard approach for operable breast cancer with positive axillary lymph nodes.
    • Previous research has explored the efficacy of adjuvant chemotherapy in improving patient outcomes.

    Purpose of the Study:

    • To evaluate the effectiveness of adjuvant chemotherapy in operable breast cancer patients with histologically positive axillary lymph nodes.
    • To determine if patient factors like menopausal status or estrogen receptor status influence treatment outcomes.

    Main Methods:

    • Prospective randomized trials were conducted starting in 1973 in Milan.
    • Patients received adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil (CMF) after radical mastectomy.
    • Outcomes were assessed based on relapse-free and total survival rates.

    Main Results:

    • Adjuvant CMF chemotherapy demonstrated a significant improvement in both relapse-free and total survival rates at five years post-mastectomy.
    • Treatment efficacy correlated with the level of drug dosage and the number of positive axillary lymph nodes.
    • No significant impact of menopausal status or estrogen receptor status on treatment outcomes was observed.

    Conclusions:

    • The scientific and biological hypotheses underlying multimodal therapy for breast cancer are validated by these findings.
    • CMF chemotherapy is an effective adjuvant treatment for operable breast cancer with positive lymph nodes.
    • Further research will focus on optimizing CMF treatment duration and exploring sequential non-cross-resistant regimens.

    Related Experiment Videos